| Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma L Azzi, F Celesti, AM Chiaravalli, AKB Shaik, M Shallak, A Gatta, ... Frontiers in Immunology 15, 1387835, 2024 | | 2024 |
| Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly D Dalla Gasperina, G Veronesi, CM Castelletti, S Varchetta, S Ottolini, ... International Journal of Molecular Sciences 24 (18), 13728, 2023 | 1 | 2023 |
| The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy G Forlani, M Shallak, A Gatta, AKB Shaik, RS Accolla biomedical journal, 100631, 2023 | 8 | 2023 |
| Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA F Celesti, A Gatta, M Shallak, AM Chiaravalli, M Cerati, F Sessa, ... Frontiers in Immunology 14, 1133177, 2023 | 6 | 2023 |
| Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine L Azzi, D Dalla Gasperina, G Veronesi, M Shallak, V Maurino, A Baj, ... EBioMedicine 88, 2023 | 22 | 2023 |
| OS08. 5. A Adenovirus-mediated delivery of the MHC-II Transactivator CIITA gene induces tumor cell killing in immunocompetent glioblastoma organoids I Salvato, E Klein, G Forlani, A Poli, A Oudin, V Baus, A Golebiewska, ... Neuro-Oncology 24 (Suppl 2), ii19, 2022 | | 2022 |
| The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing M Shallak, T Alberio, M Fasano, M Monti, I Iacobucci, J Ladet, F Mortreux, ... Frontiers in Immunology 13, 939863, 2022 | 8 | 2022 |
| Safety and immunogenicity of synchronous COVID19 and influenza vaccination A Baj, D Dalla Gasperina, D Focosi, G Forlani, FD Ferrante, F Novazzi, ... Journal of Clinical Virology Plus 2 (3), 100082, 2022 | 7 | 2022 |
| A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line E Pilotti, A Cannata, G Magnani, F Bignami, A Corsi, MT Valenti, ... International Journal of Molecular Sciences 23 (14), 7583, 2022 | | 2022 |
| Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma MW Löffler, S Gori, F Izzo, A Mayer-Mokler, PA Ascierto, A Königsrainer, ... Clinical Cancer Research 28 (12), 2555-2566, 2022 | 35 | 2022 |
| Reply to the Letter to the Editor:“Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine” by Francavilla B et al … L Azzi, D Dalla Gasperina, RS Accolla, G Forlani EBioMedicine 79, 2022 | 2 | 2022 |
| Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells F Celesti, L Azzi, M Shallak, A Gatta, R Accolla, G Forlani XX NIBIT MEETING Book of Abstract, 2022 | | 2022 |
| Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies … A Gatta, F Celesti, A Chiaravalli, M Cerati, M Shallak, A Tedeschi, F Sessa, ... XX NIBIT MEETING Book of Abstract, 2022 | | 2022 |
| Mucosal immune response in BNT162b2 COVID-19 vaccine recipients L Azzi, D Dalla Gasperina, G Veronesi, M Shallak, G Ietto, D Iovino, A Baj, ... EBioMedicine 75, 2022 | 172 | 2022 |
| Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia G Forlani, M Shallak, A Tedeschi, I Cavallari, A Marçais, O Hermine, ... Haematologica 106 (8), 2076, 2021 | 17 | 2021 |
| HTLV-1 infection and pathogenesis: new insights from cellular and animal models G Forlani, M Shallak, RS Accolla, MG Romanelli International Journal of Molecular Sciences 22 (15), 8001, 2021 | 32 | 2021 |
| Results of the therapetuic cancer vaccine HepaVac-101 clinical trial in HCC patients M Loeffler, F Izzo, S Gori, A Mayer, A Konigsrainer, YT Ma, B Sangro, ... JOURNAL OF HEPATOLOGY 75, S246-S246, 2021 | | 2021 |
| An episode of oral mucositis after the first administration of the ChAdOx1 COVID‐19 vaccine L Azzi, M Toia, N Stevanello, F Maggi, G Forlani Oral diseases, 2021 | 19 | 2021 |
| HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity RS Accolla, G Forlani, M Shallak Immunology and Cancer Biology, 2021 | | 2021 |
| HTLV-1 Infection and Adult T Cell Leukemia: Mechanisms of Oncogenesis and Alteration of Immunity M Shallak, G Forlani, RS Accolla | | 2021 |
